Ayala Pharmaceuticals Inc. (AYLA) NASDAQ
$0.50 - (-)
Market Cap: -
As of 01/18/23 12:00 AM EST. Market closed.
Ayala Pharmaceuticals Inc. (AYLA)
NASDAQ
$0.50
- (-)
Market Cap: -
As of 01/18/23 12:00 AM EST. Market closed.
Add to Portfolio
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Ayala's approach is focused on predicating, identifying and addressing tumorigenic drivers of cancer through a combination of its bioinformatics platform and next-generation sequencing to deliver targeted ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
35
Address
.
PRICE CHART FOR AYALA PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.50
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
14,820,727
Open
-
Previous Close
$0.50
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
14,820,727
FINANCIAL STATEMENTS FOR AYALA PHARMACEUTICALS INC
LOADING...
INSIDER TRANSACTIONS FOR AYALA PHARMACEUTICALS INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
SIDRANSKY DAVID | Director | Dec 23, 2020 | Buy | $11.56 | 4 | 46 | 250 | Mar 08, 2021, 04:15 PM |
SIDRANSKY DAVID | Director | May 08, 2020 | Buy | $15.27 | 200 | 3,054 | 200 | Mar 08, 2021, 04:15 PM |
SIDRANSKY DAVID | Director | Sep 14, 2020 | Buy | $10.70 | 1 | 11 | 246 | Mar 08, 2021, 04:15 PM |
SIDRANSKY DAVID | Director | Sep 11, 2020 | Buy | $10.07 | 10 | 101 | 245 | Mar 08, 2021, 04:15 PM |
SIDRANSKY DAVID | Director | Aug 14, 2020 | Buy | $11.07 | 5 | 55 | 235 | Mar 08, 2021, 04:15 PM |
SIDRANSKY DAVID | Director | Jul 17, 2020 | Buy | $11.86 | 4 | 47 | 230 | Mar 08, 2021, 04:15 PM |
SIDRANSKY DAVID | Director | Jul 07, 2020 | Buy | $9.60 | 1 | 10 | 226 | Mar 08, 2021, 04:15 PM |
SIDRANSKY DAVID | Director | May 12, 2020 | Buy | $15.02 | 25 | 376 | 225 | Mar 08, 2021, 04:15 PM |
Gordon Gary B. | Chief Medical Officer | Feb 24, 2021 | Option Exercise | $5.16 | 3,000 | 15,480 | 11,520 | Feb 26, 2021, 05:47 PM |
Gordon Gary B. | Chief Medical Officer | Feb 24, 2021 | Sale | $17.46 | 3,000 | 52,385 | 8,520 | Feb 26, 2021, 05:47 PM |
Mamluk Roni | President & CEO | Feb 24, 2021 | Sale | $17.40 | 10,800 | 187,919 | 145,345 | Feb 24, 2021, 05:42 PM |
Mamluk Roni | President & CEO | Feb 23, 2021 | Sale | $17.89 | 7,126 | 127,483 | 156,145 | Feb 24, 2021, 05:42 PM |
Mamluk Roni | President & CEO | Feb 22, 2021 | Sale | $19.86 | 15,200 | 301,813 | 163,271 | Feb 24, 2021, 05:42 PM |
Mamluk Roni | President & CEO | Jan 21, 2021 | Sale | $15.04 | 1,406 | 21,147 | 178,471 | Jan 22, 2021, 04:05 PM |
Mamluk Roni | President & CEO | Jan 20, 2021 | Sale | $15.03 | 19,466 | 292,533 | 179,877 | Jan 22, 2021, 04:05 PM |
Gordon Gary B. | Chief Medical Officer | Jan 20, 2021 | Option Exercise | $5.16 | 3,000 | 15,480 | 11,520 | Jan 22, 2021, 04:05 PM |
Gordon Gary B. | Chief Medical Officer | Jan 20, 2021 | Sale | $15.03 | 3,000 | 45,084 | 8,520 | Jan 22, 2021, 04:05 PM |
Harel Insurance Co LTD | 10% Owner | May 12, 2020 | Buy | $15.00 | 550,000 | 8,250,000 | 2,163,834 | May 14, 2020, 08:30 PM |
Israel Biotech Fund I, L.P. | 10% Owner | May 12, 2020 | Buy | $15.00 | 225,000 | 3,375,000 | 3,315,119 | May 14, 2020, 04:41 PM |
aMoon 2 Fund Limited Partnership | 10% Owner | May 12, 2020 | Buy | $15.00 | 800,000 | 12,000,000 | 2,991,473 | May 14, 2020, 04:31 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
SIDRANSKY DAVID | Director | 12/23/2020 | 46 |
SIDRANSKY DAVID | Director | 05/08/2020 | 3,054 |
SIDRANSKY DAVID | Director | 09/14/2020 | 11 |
SIDRANSKY DAVID | Director | 09/11/2020 | 101 |
SIDRANSKY DAVID | Director | 08/14/2020 | 55 |
SIDRANSKY DAVID | Director | 07/17/2020 | 47 |
SIDRANSKY DAVID | Director | 07/07/2020 | 10 |
SIDRANSKY DAVID | Director | 05/12/2020 | 376 |
Gordon Gary B. | Chief Medical Officer | 02/24/2021 | 15,480 |
Gordon Gary B. | Chief Medical Officer | 02/24/2021 | 52,385 |
Mamluk Roni | President & CEO | 02/24/2021 | 187,919 |
Mamluk Roni | President & CEO | 02/23/2021 | 127,483 |
Mamluk Roni | President & CEO | 02/22/2021 | 301,813 |
Mamluk Roni | President & CEO | 01/21/2021 | 21,147 |
Mamluk Roni | President & CEO | 01/20/2021 | 292,533 |
Gordon Gary B. | Chief Medical Officer | 01/20/2021 | 15,480 |
Gordon Gary B. | Chief Medical Officer | 01/20/2021 | 45,084 |
Harel Insurance Co LTD | 10% Owner | 05/12/2020 | 8,250,000 |
Israel Biotech Fund I, L.P. | 10% Owner | 05/12/2020 | 3,375,000 |
aMoon 2 Fund Limited Partnership | 10% Owner | 05/12/2020 | 12,000,000 |
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR AYALA PHARMACEUTICALS INC
LOADING...